CARMAT

General Info

IPO Date
07-Jul-2010
ISIN Code
FR0010907956
Location
Paris
Subsector
Medical Equipment

Background Info

Activity

Created in June 2008, CARMAT SAS is an innovative medtech start-up financed by TRUFFLE CAPITAL, EADS and the Professor Carpentier with additional funding from the French state innovation agency OSEO.

CARMAT has developed a totally implantable artificial heart which features the left and right ventricles. Its hi-tech design seeks to make the device as similar as possible to the human heart.
The CARMAT project has been spun off of the collaboration between Professor Carpentier in cardiovascular surgery and EADS on implementing biomaterials and cutting-edge technologies in the artificial heart field. The project is based on 15 years of development experience.

Personnel Info

Company Website
http://www.carmatsas.com
Issuer Website
http://www.carmatsas.com
Listing Sponsors

Dexia Securities France

back

DISCLAIMER - RESTRICTED ADDRESSEES

DISCLAIMER - RESTRICTED ADDRESSEES

The above information is for informational purposes only without regard to any particular user’s investment objectives, financial situation or means. Accordingly, it is not directed at or intended for publication or distribution to any person in any jurisdiction where doing so would result in contravention of any applicable laws or regulations. In particular, the securities above mentioned may be subject to selling restrictions in certain jurisdictions. Therefore, please note that information contained in the offering document(s) associated to the products or investments described therein may be addressed to and/or targeted at persons who are residents of particular countries or states only, as further described in the offering document(s).

In this context:

i)                    all the persons using this service should inform themselves about and comply with any such restrictions.Any failure to comply with those restrictions may constitute a violation of the securities law of any such jurisdictions.

ii)                   information contained in the offering document(s) is not intended for use, and it should not be relied upon, by any person outside the particular countries or states, as further described in the offering document(s), and/or to whom any offer contained in the offering document(s) is not addressed.

In particular, unless this document specifically states otherwise, the securities mentioned therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and, if not so registered, may not be offered or sold within the United States except in certain transactions exempt from, or not subject to, the registration requirements of the Securities Act.

Prior to relying on the information contained in any associated offering document(s), it is the responsibility of the individual user to consider his or her legal and regulatory position in the relevant jurisdiction (in particular whether or not he or she is part of the intended addressees), the risks associated with trading such securities or investments and to ensure that the use of the information available and the subsequent making of any investment does not contravene any such restrictions or applicable laws and regulations of any jurisdiction. Potential users of products or investments described above (including those wishing to trade them or to offer and sell them to others) should familiarize themselves with the full contract specification of the security or investment concerned and any associated information, such as any applicable legal or regulatory provisions. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific security, investment, index, report, opinion, advice or other content.